Scheme Information
Product Information
Analyte Data
Analyte Name
Range
Units
Accreditation
(-)-11-Nor-9-carboxy-delta9-THC
-
µg/L
(±)-Methadone
-
µg/L
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
-
µg/L
6-Acetylmorphine
-
µg/L
Amfetamine
-
μg/L
Amfetamines screen
-
μg/L
Barbiturates Screen
-
μg/L
Benzodiazepines screen
-
μg/L
Benzoylecgonine
-
μg/L
Buprenorphine and Metabolite Screen
-
μg/L
Buprenorphine or Metabolites
-
μg/L
Cannabinoid Screen
-
μg/L
Cocaine
-
μg/L
Cocaine and Metabolite Screen
-
μg/L
Codeine
-
μg/L
Delta-9-THC-COOH
-
μg/L
Dihydrocodeine
-
μg/L
EDDP Screen
-
μg/L
Hydrocodone
-
μg/L
Hydromorphone
-
μg/L
LSD and Metabolite Screen
-
μg/L
LSD or metabolites
-
μg/L
MDMA/MDA/MDEA
-
μg/L
Methadone Screen
-
μg/L
Methyl-amfetamine
-
μg/L
Morphine (total)
-
μg/L
Opiates screen
-
μg/L
Other amfetamine
-
μg/L
Oxycodone
-
μg/L
Oxymorphone
-
μg/L
Phencyclidine (PCP)
-
µg/L
Phencyclidine Screen
-
μg/L
Propoxyphene and Metabolite Screen
-
μg/L
Propoxyphene or metabolites
-
μg/L
Specific barbiturate
-
μg/L
Specific benzodiazepine
-
μg/L
Full membership = individual analytes by chromatography type techniques and screening only analytes using immunoassay type techniques. For Clinical and EWDTS thresholds, please see the DAU Scheme Description.
For details on the full technical specification of the scheme, please refer to the Scheme Description.
Read more